Part of Phaidon International![]()
Showing 592 results
Sort by:
Rare Disease Account ManagerRegion: Multiple openings across the Northeast (ME, NH, VT, CT, MA, RI, CT, NJ, DE, NY) Position Summary:The Rare Disease Account Manager is responsible for driving territory performance through strategic account management, specialist engagement, and execution of launch objectives within an assigned geography.This ind...
Rare Disease Account ManagerMultiple openings across the North Central Region (ND, SD, IA, MN & NE) Please only apply if you live in the states listed above! Position SummaryThe Rare Disease Account Manager is responsible for driving territory performance through strategic account management, specialist engagement, and execution of launch objective...
Rare Disease Account ManagerMultiple openings across the Central Plains (AR, MO, KS, and OK)Please only apply if you live in the states listed above! Position SummaryThe Rare Disease Account Manager is responsible for driving territory performance through strategic account management, specialist engagement, and execution of launch objectives within...
Take the first step toward your next opportunity - submit your resume and get started today.

Rare Disease Account ManagerRegion: Multiple openings across the Great Lakes region (WI, IL, MI, OH, IN, PA, KY, WV) Position Summary:The Rare Disease Account Manager is responsible for driving territory performance through strategic account management, specialist engagement, and execution of launch objectives within an assigned geography.This ind...
Senior Specialist, Clinical Safety $130,000-$140,000 Remote (USA) Reporting to Clinical Safety leadership, the Senior Specialist, Clinical Safety will support the safety oversight of multiple ongoing clinical studies for innovative cardiovascular medical devices. This individual will independently manage a high volume of concurrent safety activitie...
Regional Sales DirectorEPM Scientific is partnering with a rapidly growing biotechnology company following the FDA approval and U.S. launch of a breakthrough first-in-class therapy in dermatology and autoimmune disease.The approval represents a major inflection point for the business. The company is now investing in a broader commercial expansion ...